Company: FVN
Filing Date: 2025-05-30
Form Type: S-4/A
Source: 0001829126-25-004067
Chunk: 75

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-30
Form: S-4/A
Chunk 75
---
 by third parties, third parties could develop and commercialize products and technologies similar or identical to ours and compete directly against us, and our ability to successfully commercialize any product or technology may be adversely affected. |

| ● | We enjoy only limited geographical protection with respect to certain intellectual property and may not be able to protect our intellectual property rights throughout the world. |

| ● | Intellectual property rights do not necessarily protect all aspects of our intellectual property, and if we are unable to maintain the confidentiality of our trade secrets, our business and future prospect will be harmed. We also may be subject to claims that our employees, consultants, or advisers have wrongfully used or disclosed alleged trade secrets of their former employers or claims asserting ownership of what we regard as our own intellectual property. |

| ● | We may become involved in lawsuits to protect or enforce our intellectual property, which could be expensive, time-consuming and unsuccessful. Our patent rights could be found invalid or unenforceable if challenged in court or before the relevant patent authority. |

| ● | Intellectual property litigation may lead to unfavorable publicity which may harm our reputation and cause the market price of our ordinary shares to decline, and any unfavorable outcome from such litigation could limit our R&D activities and/or our ability to commercialize our service offerings and products. |

| ● | If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our competitive position may be adversely affected. |

| ● | If our efforts to protect the proprietary nature of the intellectual property related to our technologies are not adequate, we may not be able to compete effectively in our market. |

<div align='center'>37</div>

Risks Related to New VIWO’s Status as a Foreign Private Issuer

| ● | New VIWO will convert                                                                                                                
 to foreign private issuer status within the meaning of the rules under the Exchange Act upon the first available determination date, 
 and, as such, New VIWO will be exempt from certain provisions applicable to United States domestic public companies. New VIWO may    
 lose its status as a foreign private issuer in the future, causing it to incur substantial costs, time and resources.                |

| ● | As an exempted company incorporated in the Cayman Islands, New VIWO will be permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq listing standards; these practices may afford less protection to shareholders than they would enjoy if New VIWO complied fully with the Nasdaq listing